Current and Emerging Systemic Therapies for Renal Cell Carcinoma: Clinical Evidence and Guideline Recommendations

Get up to date on multidisciplinary management of renal cell carcinoma with downloadable slides and an on-demand webcast plus an expert commentary from a live webinar on the most important data from ASCO GU 2022.

Share

Program Content

Activities

RCC: Adjuvant Approaches and First-Line Therapy for Advanced Disease
Considerations for Selecting Systemic Therapy for Patients with RCC: Adjuvant Approaches and First-Line Therapy for Advanced Disease
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 01, 2022

Expires: February 28, 2023

RCC: Second-Line Therapy and Beyond
Optimal Treatment for Patients With Progressive RCC After 1 or More Previous Lines of Therapy
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 01, 2022

Expires: February 28, 2023

RCC: Managing AEs
Optimal Management of Immune-Related Adverse Events for Patients With Advanced RCC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 01, 2022

Expires: February 28, 2023

Activities

FAQ: Adjuvant Tx for RCC
Experts Answer HCP Questions on Adjuvant Therapy for Renal Cell Carcinoma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 13, 2022

Expires: April 12, 2023

FAQ: Tx for Metastatic RCC
Experts Answer HCP Questions on Therapy for Metastatic Renal Cell Carcinoma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 13, 2022

Expires: April 12, 2023

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Exelixis, Inc.

Merck Sharp & Dohme Corp.

Pfizer, Inc.